Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
970 DKK | -0.34% |
|
+0.41% | +38.95% |
11:17am | Novo Nordisk's Main Owner Leads $100 Million Financing of Biotech Firm Asceneuron | DJ |
09:00am | Novo owner backs Swiss biotech Asceneuron in $100 million round | RE |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+38.95% | 631B | |
+62.02% | 856B | |
-4.17% | 359B | |
+15.57% | 325B | |
+9.22% | 297B | |
+5.89% | 234B | |
+16.53% | 226B | |
+16.13% | 177B | |
+2.31% | 165B | |
+2.41% | 126B |
- Stock Market
- Equities
- NOVO B Stock
- News Novo Nordisk A/S
- NOVO NORDISK : JP Morgan reiterates its Buy rating